BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36699747)

  • 1. Clinicopathological Profile of Paraprotein-Associated Kidney Disease in Monoclonal Gammopathies: An Observational Study.
    Parepalli D; Srinivas BH; Basu D; Ps P; Dubashi B
    Cureus; 2022 Dec; 14(12):e32929. PubMed ID: 36699747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
    Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
    Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Paraprotein-related kidney disease. Experience in 22 cases].
    Jerez J; Juanet C; Sharp J; Ernst D; Méndez GP; Sepúlveda RA
    Rev Med Chil; 2020 Aug; 148(8):1059-1067. PubMed ID: 33399771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.
    Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH
    Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics and prognosis in patients with monoclonal gammopathy and renal damage in central China: a multicenter retrospective cohort study.
    He H; Wang Z; Xu J; Liu Y; Shao Y; Hou Y; Gu J; Hu R; Xing G
    Sci Rep; 2024 Apr; 14(1):7667. PubMed ID: 38561447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
    Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW
    Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinic-pathological characteristics of rare tubulointerstitial diseases.
    Shi K; Yuan S; Huang Y; Li Z; Wang C; Liu H; Sun L; Liu F; Zhu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1365-1374. PubMed ID: 36411687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathy: significance and possible causality in renal disease.
    Paueksakon P; Revelo MP; Horn RG; Shappell S; Fogo AB
    Am J Kidney Dis; 2003 Jul; 42(1):87-95. PubMed ID: 12830460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies.
    Nasr SH; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Lacy M; Dispenzieri A; Rajkumar SV; Kyle RA; Leung N
    Am J Kidney Dis; 2012 Jun; 59(6):786-94. PubMed ID: 22417785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple morphological phenotypes of monoclonal immunoglobulin disease on renal biopsy: Significance of treatment.
    Adapa S; Konala VM; Naramala S; Nast CC
    Clin Nephrol Case Stud; 2020; 8():17-24. PubMed ID: 32318322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
    Sethi S; Fervenza FC; Rajkumar SV
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal Immunoglobulin Deposition Disease and Related Diseases.
    Kanzaki G; Okabayashi Y; Nagahama K; Ohashi R; Tsuboi N; Yokoo T; Shimizu A
    J Nippon Med Sch; 2019; 86(1):2-9. PubMed ID: 30918151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide for the Treatment of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposition.
    Asif S; Mahmood SN; Mukhtar KN
    Saudi J Kidney Dis Transpl; 2021; 32(4):1166-1170. PubMed ID: 35229819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal Gammopathies of Renal Significance: Renal Biopsy and Beyond.
    Menè P; De Alexandris L; Moioli A; Raffa S; Stoppacciaro A
    Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32629844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological characteristics of patients with paraproteinemia and renal damage.
    Tang X; Wan F; Yu J; Li X; Yang R; Zhu B
    Eur J Med Res; 2021 Jul; 26(1):68. PubMed ID: 34217367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Types of M protein and clinicopathological profiles in patients with monoclonal gammopathy of renal significance.
    Liang D; Liu J; Liang S; Xu F; Cheng Z; Huang X; Zeng C; Liu Z
    J Nephrol; 2021 Aug; 34(4):1137-1146. PubMed ID: 32725498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotic syndrome secondary to amyloidosis in a patient with monoclonal gammopathy with renal significance (MGRS).
    Niculae A; Peride I; Vinereanu V; Rădulescu D; Bratu OG; Geavlete BF; ChecheriŢă IA
    Rom J Morphol Embryol; 2017; 58(3):1065-1068. PubMed ID: 29250691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term renal survival of γ3-heavy chain deposition disease: a case report.
    Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S
    BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.